Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06305884 · ClinicalTrials.gov registry record · NA
Transcutaneous Sensors for the Detection of Cancer-Related Lymphedema, Project Limb Rescue Study
A NA study of Malignant Solid Neoplasm and Lymphedema, sponsored by Ohio State University Comprehensive Cancer Center.
- Active
- Registry status
- NA
- Development phase
- 76
- Enrollment target
- 1
- Study location
NCT06305884 is a NA study of Malignant Solid Neoplasm and Lymphedema that is active but no longer recruiting, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 76 participants, below the 1,140-participant average among 176 other Malignant Solid Neoplasm trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06305884, a NA study of Malignant Solid Neoplasm and Lymphedema, is active but no longer recruiting, sponsored by Ohio State University Comprehensive Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 76 participants
- Enrollment target
- 1
- Study location
Study Summary
This clinical trial studies how well new adhesive-based sensors that stick to the skin (transcutaneous) work in detecting cancer-related long-term arm swelling (lymphedema). For many patients, lymphedema s painful, unsightly, and weakening. The early signs of lymphedema are hard to see, and sometimes it is only diagnosed by hospital equipment at larger centers. Treating lymphedema early is usually more successful than trying to treat in later stages. The adhesive-based sensors used in this study work by using techniques called photoplethysmography (PPG) and bioimpedance (BI). PPG is an optical technique that can be used to detect blood volume changes in tissue. BI evaluates how tissue responds to an externally applied electrical current. This study may assist researchers in distinguishing participants with lymphedema in comparison to participants without lymphedema, and develop a way for patients to check for lymphedema at home.
Conditions Studied
Interventions
- OTHER Exercise
- PROCEDURE Bioelectric Impedance Analysis
- PROCEDURE Photoplethysmography
- BEHAVIORAL Questionnaire Administration
Study Locations (1)
Ohio
- Ohio State University Comprehensive Cancer Center - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2024-04-22 |
| Est. Completion | 2026-02-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06305884
The ClinicalTrials.gov registry entry for NCT06305884 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 76 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,140-participant average among 176 other Malignant Solid Neoplasm trials with a reported enrollment target (93% lower). The listed sponsor is Ohio State University Comprehensive Cancer Center, which has 341 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Malignant Solid Neoplasm appearing as the primary indexed condition, and to 4 interventions - of which Exercise is the first listed.
NCT06305884 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT06305884 about?
NCT06305884 is a clinical study titled "Transcutaneous Sensors for the Detection of Cancer-Related Lymphedema, Project Limb Rescue Study". This clinical trial studies how well new adhesive-based sensors that stick to the skin (transcutaneous) work in detecting cancer-related long-term arm swelling (lymphedema). For many patients, lymphedema s painful, unsightly, and weakening. The early signs of lymphedema are hard to see, and sometime...
What is the current status of trial NCT06305884?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 76 participants. The study started on 2024-04-22. Estimated completion is 2026-02-20.
What conditions does trial NCT06305884 study?
This clinical trial studies the following conditions: Malignant Solid Neoplasm, Lymphedema, Hematopoietic and Lymphoid System Neoplasm.
What interventions are being tested in trial NCT06305884?
The interventions under investigation include: Exercise (OTHER), Bioelectric Impedance Analysis (PROCEDURE), Photoplethysmography (PROCEDURE), Questionnaire Administration (BEHAVIORAL).
Who is sponsoring clinical trial NCT06305884?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06305884 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Malignant Solid Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Exercise Program (TEAM Me) for the Improvement of Movement and Mobility in Pediatric and Adolescent and Young Adult Patients With Cancer Undergoing a Blood Stem Cell Transplant
RECRUITING · NA
-
Genetic Testing for the Prevention of Cancer in Indigenous American Communities (JUNIPER Trial)
RECRUITING · NA
-
Acupressure for the Reduction of Anxiety in Patients Receiving Cancer-Directed Therapy
RECRUITING · NA
-
Aromatherapy Essential Oils to Manage Anxiety and Nausea in Cancer Patients Receiving Infusion in the Ambulatory Setting
RECRUITING · NA
-
Community-Based Physical Activity Intervention for Underserved Cancer Survivors
RECRUITING · NA
-
Comparing Telephone Symptom Monitoring Interventions for Managing Symptoms and Psychological Distress During Oral Anti-Cancer Treatment
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.